Lidia Maria Rebolho Batista Arantes

15PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyHealth informatics and information systemsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 06, 2026
Dendritic cell-based immunotherapy modulates the systemic inflammatory profile in a 4T1 breast cancer model.

|Jul 25, 2026
A baseline systemic inflammatory signature predicts anti-PD-1 response in advanced melanoma.

|Jul 15, 2026
The tumoural landscape of lymphocytes and immune pathways in immunotherapy-treated melanoma patients.

|Oct 24, 2025
Monocyte-Platelet-Hemoglobin-Hematocrit score and the role of hematological parameters in predicting treatment response to immune checkpoint inhibitors and survival outcomes in non-small cell lung cancer patients-a retrospective study.

Katiane Tostes, Tauana Christina Dias, Gabriela Karam Rebolho

|May 03, 2025
CD24, NFIL3, FN1, and KLRK1 signature predicts melanoma immunotherapy response and survival.

Bruna Pereira Sorroche, Renan de Jesus Teixeira, Vinicius Gonçalves de Souza

|Feb 25, 2025
Advanced Stage Head and Neck Cancer Diagnosis: HEADSpAcE Consortium Health Systems Benchmarking Survey.

Grant Creaney, Mariél de Aquino Goulart, Alex McMahon

Pageof 3

Frequent Collaborators

7 joint publications

Bruna Pereira Sorroche

6 joint publications

Katiane Tostes

5 joint publications

Renan de Jesus Teixeira

3 joint publications

Vinicius Gonçalves de Souza